ZWI-ZW25-301
Active, not recruiting
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
Study Overview
Sex:
All 
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents